Efficacy and Safety of Modified Si Jun Zi Tang in Perioperative NSCLC Treatment
NCT06445881
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Perioperative Complication
Interventions
DRUG:
Modified Si Jun Zi Tang
Sponsor
First Affiliated Hospital of Zhejiang University